Antoine Racine

Antoine Racine

UNVERIFIED PROFILE

Are you Antoine Racine?   Register this Author

Register author
Antoine Racine

Antoine Racine

Publications by authors named "Antoine Racine"

Are you Antoine Racine?   Register this Author

51Publications

3479Reads

29Profile Views

Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC).

Inflamm Bowel Dis 2017 12;23(12):2072-2082

1Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom; 2Program in Public Health, College of Health Sciences, University of California, Irvine, California; 3Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; 4Biomarker Group, Nutrition and Metabolism Section, International Agency for Research on Cancer (IARC), Lyon, France; 5Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain; 6Department of Medicine, Norwich Medical School, University of East Anglia, Norwich, United Kingdom; 7Norfolk and Norwich University Hospital NHS Trust, Norwich, United Kingdom; 8Strangeways Research Laboratory, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom; 9Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands; 10Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden; 11Department of Public Health and Clinical Medicine, GI Unit, Umeå University, Umeå, Sweden; 12Department of Clinical Sciences, University Hospital, Malmö, Sweden; 13Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom; 14Department of Epidemiology, German Institute of Human Nutrition, Potsdam, Germany; 15Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark; 16Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Centre, Florence, Italy; 17INSERM, Centre for Research in Epidemiology and Population Health, U1018, Team 9, Institut Gustave Roussy, Villejuif, France; 18Université Paris Sud, UMRS 1018, Villejuif, France; 19Department of Gastroenterology, Bicêtre University Hospital, Assistance Publique des Hôpitaux de Paris, Le Kremlin Bicêtre, France; 20Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; 21Focused Research Unit for Molecular and Clinical Research, Institute of Regional Research- Center Sønderjylland, University of Southern Denmark, Odense, Denmark; 22Laboratory Center, Hospital of Southern Jutland, Aabenraa, Denmark; 23Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 24Division of Clinical Epidemiology, DKFZ-German Cancer Research Centre, Heidelberg, Germany; 25Cancer Registry and Histopathology Unit, "Civic-M.P.Arezzo" Hospital, ASP Ragusa, Italy; and 26WHO Collaborating Center for Food and Nutrition Policies, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000001108DOI Listing
December 2017

Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy.

Inflamm Bowel Dis 2016 06;22(6):1362-9

1CHU de Bordeaux, Hôpital Haut-Le[Combining Acute Accent]vêque, Service d'He[Combining Acute Accent]pato-gastroente[Combining Acute Accent]rologie, University of Bordeaux, Bordeaux, Pessac, France; 2Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine, ERL 1157 INSERM/UMRS 7203, DHU 12B, UPMC, Paris, France; 3Department of Gastroenterology, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris, Paris Est Creteil University, Paris, France; 4CHRU de Lille, Hôpital Claude Huriez, Service des Maladies de l'Appareil Digestif-Endoscopie Digestive, Lille, France; 5Department of Gastroenterology, Cochin Hospital, Assistance Publique Hôpitaux de Paris and Paris V University, Paris, France; 6Hôpital Beaujon, Gastroente[Combining Acute Accent]rologie, Maladies Inflammatoires Chroniques de l'Intestin et Assistance Nutritive, AP-HP, Universite[Combining Acute Accent] Paris VII, Clichy, France; 7Department of Gastroenterology, CHU of Liège, University of Liège, Belgium; 8GIGA Research, University of Liege, Belgium; 9Service d'He[Combining Acute Accent]pato-Gastroente[Combining Acute Accent]rologie, CHU Amiens, Université de Picardie Jules Verne, Amiens, France; 10Department of Gastroenterology, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; 11Department of Gastroenterology, Lyon Sud Hospital, Hospices Civils de Lyon, Pierre Benite, France; 12INSERM U1111, CIRI, Lyon, France; 13INSERM U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, Université Henri Poincaré 1, Vandoeuvre-lès-Nancy, France; 14Inserm CIC 1114 and Institut des Maladies de l'Appareil Digestif, University Hospital, Nantes, France; 15CHU de Nice, Hôpital de l'Archet 2, Service de Gastroente[Combining Acute Accent]rologie et Nutrition Clinique, Nice, France; 16Department of Hepato-Gastroenterology and Digestive Oncology Hôpital Robert Debré, Reims, France; 17CHU de Rouen, Hôpital Charles Nicolle, Service de Gastroente[Combining Acute A

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000741DOI Listing
June 2016

Dairy Products, Dietary Calcium, and Risk of Inflammatory Bowel Disease: Results From a European Prospective Cohort Investigation.

Inflamm Bowel Dis 2016 06;22(6):1403-11

1Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands; 2Department of Medicine, Norwich Medical School, University of East Anglia, Norwich, United Kingdom; 3Department of Gastroenterology, Norfolk and Norwich University Hospital NHS Trust, Norwich, United Kingdom; 4Strangeways Research Laboratory, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom; 5Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden; 6Department of Public Health and Clinical Medicine, GI Unit, Umeå University, Umeå, Sweden; 7Department of Clinical Sciences, Lund University, Lund, Sweden; 8Gastroenterology-Hepatology Division, University Hospital Skane, Malmö, Sweden; 9Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom; 10Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Potsdam, Germany; 11Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 12Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy; 13French Institute of Health and Medical Research (INSERM), Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, Villejuif, France; 14Université Paris Sud, Paris, France; 15Department of Gastroenterology, Bicêtre University Hospital, Assistance Publique des Hôpitaux de Paris, Paris, France; 16Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark; 17Institute of Regional Research, Center Sønderjylland, University of Southern Denmark, Odense, Denmark; 18Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 19Cancer Registry and Histopathology Unit, "Civic-M.P. Arezzo" Hospital, Ragusa, Italy; 20Department of Hygiene and Epidemiology, WHO Collaborating Center for Food and Nu

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000798DOI Listing
June 2016

Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study.

Inflamm Bowel Dis 2016 Feb;22(2):345-54

1INSERM, Centre for Research in Epidemiology and Population, Health, UMR1018, Institut Gustave Roussy, Université Paris Sud, Villejuif, France; 2Department of Gastroenterology, University Hospital of Bicêtre, Assistance Publique Hôpitaux de Paris, Université Paris-Sud, Le Kremlin Bicêtre, France; 3Department of Medicine, Norwich Medical School, University of East Anglia, Norwich, United Kingdom; 4Department of Gastroenterology, Norfolk and Norwich University Hospital NHS Trust, Norwich, United Kingdom; 5Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 6Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the Netherlands; 7Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom; 8Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; 9Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 10Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 11Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 12Strangeways Research Laboratory, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom; 13Division of Epidemiology, Imperial College London, London, United Kingdom; 14Department of Gastroenterology and Hepatology, University Hospital Malmö, Malmö, Sweden; 15Department of Public Health and Clinical Medicine, Nutritional Research, Umea University, Umea, Sweden; 16Department of Public Health and Clinical Medicine, GI unit, Umea University, Umea, Sweden; 17Department of Epidemiology, German Institute of Human Nutrition, Potsdam, Germany; 18Division of Clinical Epidemiology, DKFZ-German Cancer Research Centre Heidelberg, Heidelberg, Germany; 19Molecular and Nutritional Epidemio

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000638DOI Listing
February 2016

The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition.

Am J Clin Nutr 2015 Dec 11;102(6):1498-508. Epub 2015 Nov 11.

Hellenic Health Foundation, Athens, Greece; Department of Epidemiology, Harvard School of Public Health, Boston, MA; Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece;

View Article

Download full-text PDF

Source
https://www.diva-portal.org/smash/get/diva2:890024/FULLTEXT0
Web Search
http://ajcn.nutrition.org/cgi/doi/10.3945/ajcn.115.116095
Publisher Site
http://dx.doi.org/10.3945/ajcn.115.116095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658462PMC
December 2015

A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.

J Natl Cancer Inst 2015 Apr 23;107(4). Epub 2015 Feb 23.

Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrueke, Nuthetal, Germany (KA, HB); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK (SCC, BBdM, MJG, YL, AJC, ER, PV); Division of Health Policy Translation, Institutes of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan (SCC); Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway (HZ, GST); Molecular Epidemiology Group, Max Delbrueck Center for Molecular Medicine, Berlin-Buch, Germany (TP); International Agency for Research on Cancer, Lyon, France (MJe, SYJK, HF, MJo); National Institute for Public Health and the Environment, Bilthoven, the Netherlands (BBdM); Department of Gastroenterology and Hepatology, University Medical Center, Utrecht, the Netherlands (BBdM); Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway (SEV); Division of Epidemiology, Norwegian Institute of Public Health, Bergen, Norway (SEV); Bevital AS, Bergen, Norway (ØM); Section for Pharmacology, Department of Clinical Science, University of Bergen, Bergen, Norway (HZ, PMU); Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway (PMU); Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA (VF); Winship Cancer Institute, Emory University, Atlanta, GA (VF); Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway (EW); Department of Research, Cancer Registry of Norway, Oslo, Norway (EW); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (EW); Samfundet Folkhälsan, Helsinki, Finland (EW); Human Genetics Foundation (HuGeF), Torino, Italy (GS, PV); Inserm, Centre for research in Epidemiology and Population Health, U1018, Nutrition, Hormones and Women's Health team, F-94805, Villeju

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402364PMC
April 2015

Carbohydrate intake in the etiology of Crohn's disease and ulcerative colitis.

Inflamm Bowel Dis 2014 Nov;20(11):2013-21

1Norwich Medical School, Department of Medicine, University of East Anglia, Norwich, United Kingdom; 2Department of Gastroenterology, Norfolk and Norwich University Hospital NHS Trust, Norwich, United Kingdom; 3Strangeways Research Laboratory, Institute of Public Health, University of Cambridge, United Kingdom; 4University Medical Center Utrecht, Department of Gastroenterology and Hepatology, Utrecht, the Netherlands; 5National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 6Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom; 7Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden; 8Department of Public Health and Clinical Medicine, GI Unit, Umeå University, Umeå, Sweden; 9Department of Clinical Sciences, University Hospital, Malmö, Sweden; 10Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom; 11Department of Epidemiology, German Institute of Human Nutrition, Potsdam, Germany; 12Department of Clinical Epidemiology, University of Aarhus, Denmark; 13Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Centre, Florence, Italy; 14INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, Paris, France; 15Université Paris Sud, UMRS 1018, Paris, France; 16Department of Gastroenterology, Bicêtre University Hospital, Assistance Publique des Hôpitaux de Paris, Paris, France; 17Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 18Division of Clinical Epidemiology, DKFZ-German Cancer Research Centre, Heidelberg, Germany; 19Cancer Registry and Histopathology Unit, "Civic - M.P.Arezzo" Hospital, Ragusa, Italy; 20WHO Collaborating Center for Food and Nutrition Policies, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000168DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213135PMC
November 2014

Colonoscopy reduced distal colorectal cancer risk and excess cancer risk associated with family history.

Cancer Causes Control 2014 Oct 22;25(10):1329-36. Epub 2014 Jul 22.

INSERM U1018, Team 9, Institut Gustave Roussy, Espace Maurice Tubiana, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-014-0438-7DOI Listing
October 2014

Response to Dai et al.

Am J Gastroenterol 2014 Sep;109(9):1494-5

1] Department of Gastroenterology, University Hospital of Bicêtre, Assistance Publique Hôpitaux de Paris, Université Paris-Sud, Le Kremlin Bicêtre, France [2] INSERM, UMRS 1018, Team 9, Centre for Research in Epidemiology and Population Health, Université Paris-Sud, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2014.236DOI Listing
September 2014

Isotretinoin and risk of inflammatory bowel disease: a French nationwide study.

Am J Gastroenterol 2014 Apr 18;109(4):563-9. Epub 2014 Feb 18.

1] Department of Gastroenterology, University Hospital of Bicêtre, Assistance Publique Hôpitaux de Paris, Université Paris-Sud, Le Kremlin Bicêtre, France [2] INSERM, UMRS 1018, Team 9, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, Université Paris-Sud, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2014.8DOI Listing
April 2014

Weight change later in life and colon and rectal cancer risk in participants in the EPIC-PANACEA study.

Am J Clin Nutr 2014 Jan 13;99(1):139-47. Epub 2013 Nov 13.

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Netherlands (CNSB, CHvG, EMM, PHMP, and AMM); the National Institute for Public Health and the Environment, Bilthoven, Netherlands (HBB-d-M); the Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, Netherlands (HBB-d-M); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany (HB and KA); the International Agency for Research on Cancer, WHO, Lyon, France (MJ, HF, and PF); the Division of Epidemiology, Public Health and Primary Care, Imperial College, London, United Kingdom (HBB-d-M, TN, ER, and PHMP); INSERM, Centre for Research in Epidemiology and Population Health, Nutrition, Hormones and Women's Health Team, Villejuif, France (MB-R, GF, and AR); University of Paris, Sud, Villejuif, France (MB-R, GF, and AR); IGR, Villejuif, France (MB-R, GF, and AR); Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy (DP); the Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy (VK); the Cancer Registry and Histopathology Unit, "Civile M.P. Arezzo" Hospital, ASP Ragusa, Italy (RT); HuGeF-Human Genetics Foundation-Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy (A Naccarati); Dipartimento di Medicina Clinica e Chirugia, FEDERICO II University, Naples, Italy (AM); Public Health Directorate, Asturias, Spain (MVA); the Andalusian School of Public Health, Granada, Spain (MS and MJT); CIBER de Epidemiología y Salud Pública, Spain (MS, MJT, and EA); the Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain (MJT); the Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain (MJT); the Navarre Public Health Institute, Pamplona, Spain (EA); Subdirección de Salud Pública de Gipuzkoa, Gobierno Vasco, San Sebastian, Spain (MD); the Department of Epidemiology, Catalan I

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3945/ajcn.113.066530DOI Listing
January 2014

High residential sun exposure is associated with a low risk of incident Crohn's disease in the prospective E3N cohort.

Inflamm Bowel Dis 2014 Jan;20(1):75-81

*Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, Villejuif, France; †Univ Paris Sud, UMRS 1018, Villejuif, France; ‡Inserm U1018, Institut Gustave Roussy, Villejuif, France; §Sainte Justine University Hospital, Montréal, Canada; and ‖Service de Gastroentérologie, Hôpitaux Universitaires Paris Sud, CHU de Bicêtre, APHP, Le Kremlin Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.MIB.0000436275.12131.4fDOI Listing
January 2014

Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort.

CMAJ 2013 Apr 18;185(7):555-61. Epub 2013 Mar 18.

Institut national de la santé et de la recherche médicale (INSERM), the Centre for Research in Epidemiology and Population Health and Université Paris Sud, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/cmaj.121490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626807PMC
April 2013